Company intelligence / Profile preview
StradBio
- Ownership
- Private
- Development stage
- Preclinical
Overview
StradBio develops next-generation immunotherapies using precision-engineered immune agonists to activate the immune system against cancer and inflammatory diseases. Their proprietary platforms aim to maximize efficacy while minimizing side effects by controlling where and how potent immune signals are delivered. The company leverages computational protein design, logic gating, and targeted delivery for improved safety profiles. No clinical results have been published yet; programs appear preclinical.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Precision-tuned cytokine mimetics (de novo designed proteins)Split cytokine technology (conditional activation)Locked cytokine technology (site-specific chemical modification)
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on StradBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on StradBio.